STOCK TITAN

Arteris, Inc. (AIP) SEC Filings, Apr 17-28, 2026

AIP NASDAQ

Arteris, Inc. filings document a semiconductor technology business built around System IP for SoC and chiplet design. Its 8-K reports cover quarterly and annual operating results, financial-condition updates, guidance exhibits, customer shipment milestones, royalty trends and product portfolio disclosures for network-on-chip interconnect IP, SoC integration automation software and hardware security assurance.

The company’s proxy materials cover board elections, executive compensation, equity incentive arrangements and stockholder voting matters. They also describe governance and business context for Arteris’ markets, including automotive, artificial intelligence and machine learning, 5G communications, data centers, edge computing, enterprise and consumer electronics.

Rhea-AI Summary

Arteris, Inc. director Chitkara Raman sold 5,000 shares of Common Stock in an open-market transaction. The sale occurred on April 24, 2026 at a weighted average price of $25.0579 per share, with individual trades between $25.00 and $25.25.

The transaction was made under a pre-arranged Rule 10b5-1 trading plan adopted on March 7, 2025. Following this sale, Raman directly holds 147,867 shares of Arteris common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Arteris, Inc. director Antonio J. Viana, through the Viana Family Trust, sold 20,000 shares of Arteris common stock in an open-market transaction at a weighted average price of $26.1117 per share. After the sale, the trust held 124,620 shares indirectly, and Viana held 20,840 shares directly. The sale was executed under a Rule 10b5-1 trading plan adopted on June 10, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Viana Family Trust U/A DTD 07/12/2007 filed a Rule 144 notice reporting 20,000 shares of Common Stock to be sold on or about 04/24/2026 on NASDAQ. The filing notes prior 10b5-1 sales of 20,000 shares on 04/17/2026 for $442,168.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Insider sale filed on Form 144: reported disposition of 5,000 shares. The filing shows 5,000 restricted stock units granted 03/15/2022 and a 10b5-1 sale of 5,000 common shares on 04/14/2026 reporting proceeds of $100,254.00. The filing lists the broker as Morgan Stanley Smith Barney LLC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Arteris, Inc. director Saiyed Atiq Raza, through the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, reported open‑market sales of a total of 90,000 shares of Arteris common stock at weighted average prices around $22 per share under a pre‑arranged Rule 10b5‑1 trading plan. After these transactions, the trust holds 300,000 shares indirectly, and Raza also holds 20,839 shares directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.2%
Tags
insider
-
Rhea-AI Summary

Arteris, Inc. director Antonio J. Viana reported an open‑market sale of common stock through the Viana Family Trust. On April 17, 2026, the trust sold 20,000 shares at a weighted average price of $22.1084 per share under a pre‑arranged Rule 10b5-1 trading plan adopted on June 10, 2025. After this sale, the trust held 144,620 shares of Arteris common stock, while Viana also directly held 20,840 shares, indicating he retains a substantial equity position.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.2%
Tags
insider
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.2%
Tags
annual report
-
Rhea-AI Summary

Arteris, Inc. is asking stockholders to vote at its virtual 2026 Annual Meeting on June 2, 2026 to elect three Class II directors and ratify Deloitte & Touche LLP as independent auditor for 2026.

The company highlights continued growth since its 2021 IPO, reaching $70 in revenue in 2025 with customers shipping over 4 billion SoCs containing Arteris system IP, and expanding its SoC integration automation products. In January 2026 Arteris acquired Cycuity, Inc., adding semiconductor cybersecurity verification technology.

The record date is April 9, 2026, when 46,092,618 shares of common stock were outstanding. The board has seven members, a classified structure, and a lead independent director, and reports continued use of performance-based bonuses, equity awards and a formal clawback and insider trading policy. Arteris remains an “emerging growth company” with scaled executive compensation disclosure.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.2%
Tags
proxy
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Filing
Rhea-AI Summary

AIP filing a Form 144 notice reporting proposed sales of 90,000 shares of Common stock and a series of recent 10b5-1 dispositions. The excerpt lists multiple sale dates and amounts, including 106,031 and 73,610 shares on March and February 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many Arteris (AIP) SEC filings are available on StockTitan?

StockTitan tracks 243 SEC filings for Arteris (AIP), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Arteris (AIP)?

The most recent SEC filing for Arteris (AIP) was filed on April 28, 2026.